Krystal Biotech buy Chardan Capital
Start price
05.08.25
/
50%
€118.80
Target price
05.08.26
€189.46
Performance (%)
103.96%
Price
14:09
€242.30
Summary
This prediction is currently active. The BUY prediction by Chardan_Capital for Krystal Biotech has seen massive gains of 103.96%. This prediction currently runs until 05.08.26. The prediction end date can be changed by Chardan_Capital at any time. Chardan_Capital has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Krystal Biotech | 9.253% | 9.253% |
| iShares Core DAX® | 0.191% | 4.771% |
| iShares Nasdaq 100 | -0.614% | 3.137% |
| iShares Nikkei 225® | 0.599% | 8.016% |
| iShares S&P 500 | -0.036% | 3.593% |
Comments by Chardan_Capital for this prediction
In the thread Krystal Biotech diskutieren
Krystal Biotech, Inc. (NASDAQ: KRYS) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $219.00 price target on the stock.
Ratings data for KRYS provided by MarketBeat
Stopped prediction by Chardan_Capital for Krystal Biotech
Krystal Biotech
Start price
Target price
Perf. (%)
€151.90
18.12.24
18.12.24
€202.14
18.12.25
18.12.25
30.09%
19.12.25
19.12.25
Krystal Biotech
Start price
Target price
Perf. (%)
€165.85
12.12.24
12.12.24
€201.99
12.12.25
12.12.25
25.47%
13.12.25
13.12.25